| Keyword | CPC | PCC | Volume | Length string | Score |
|---|---|---|---|---|---|
| fca treatment of peps | 0.12 | 0.2 | 5630 | 21 | 21 |
| fca guidance treatment of peps | 0.6 | 1 | 1727 | 30 | 41 |
| fca guidance on peps | 1.44 | 0.4 | 6367 | 20 | 15 |
| fca review of peps | 0.5 | 1 | 7167 | 18 | 67 |
| fca pep guidance 2017 | 1.65 | 0.9 | 8306 | 21 | 95 |
| fca definition of a pep | 0.37 | 0.5 | 713 | 23 | 94 |
| pep risk assessment fca | 0.2 | 0.5 | 7404 | 23 | 18 |
| what is pep treatment | 1.14 | 1 | 3292 | 21 | 71 |
| fatf guidance on peps | 1.12 | 0.8 | 4266 | 21 | 55 |
| national clinical guidelines of pep | 1.41 | 0.4 | 8568 | 35 | 8 |
| guidance for using peds | 1.38 | 0.6 | 3637 | 23 | 53 |
| cdc guidelines for pep | 1.49 | 0.5 | 5860 | 22 | 9 |
| cdc recommendations for pep | 0.05 | 0.4 | 9204 | 27 | 30 |
